Alpine Global Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,029
Closed -$293K 464
2024
Q1
$293K Buy
+1,029
New +$301K 0.06% 142
2017
Q4
Sell
-5,316
Closed -$991K 191
2017
Q3
$991K Buy
+5,316
New +$942K 0.29% 55
2017
Q2
Sell
-4,690
Closed -$769K 137
2017
Q1
$769K Buy
+4,690
New +$779K 0.2% 101
2015
Q3
Sell
-2,699
Closed -$414K 128
2015
Q2
$414K Sell
2,699
-2,151
-44% -$345K 0.07% 207
2015
Q1
$775K Sell
4,850
-12,100
-71% -$1.91M 0.25% 92
2014
Q4
$2.7M Buy
+16,950
New +$2.64M 0.48% 46

Other funds holding AMGN

Alpine Global Management's AMGN Position: Q2 2024 in Review

Alpine Global Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,029 shares — an estimated $293K sold.

Alpine Global Management first reported a position in AMGN in Q4 2014 and held it in 6 quarters. The position peaked at $2.7M in Q4 2014. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Alpine Global Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Alpine Global Management sold 1,029 Amgen shares in Q2 2024, an estimated $293K.
  • Alpine Global Management first reported a position in Amgen in Q4 2014 and held it in 6 quarters.
  • Alpine Global Management's Amgen position peaked at $2.7M in Q4 2014.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.